Immunogenicity Data Drove Monkeypox Dose-Sparring Decision…It Also Drove Initial Approval

 
• By Sarah Karlin-Smith
  
white house monkeypox press briefing Aug. 9, 2022
Biden administration officials discuss Jynneos EUA or dose-sparing vaccine strategy 9 August. • Source: White House Press Briefing
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet